<html><head></head><body><h1>Nystatin Oral Suspension</h1><p class="drug-subtitle"><b>Dosage Form:</b> oral suspension<br/></p><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li>Overview</li>
<li>Side Effects</li>
<li>Dosage</li>
<li>Professional</li>
<li>Interactions</li>
<li class="nav-more">
More&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewBox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;&lt;/body&gt;&lt;/html&gt;
</li>
</ul><ul>
<li>Description</li>
<li>Clinical Pharmacology</li>
<li>Indications and Usage</li>
<li>Contraindications</li>
<li>Precautions</li>
<li>Adverse Reactions/Side Effects</li>
<li>Overdosage</li>
<li class="ddc-toggle-hidden">Dosage and Administration</li>
<li class="ddc-toggle-hidden">How Supplied/Storage and Handling</li>
</ul><p class="First"><span class="Bold">Rx Only</span></p><h2>Nystatin Oral Suspension Description</h2><p class="First">Nystatin is an antimycotic polyene antibiotic obtained from <span class="Italics">Streptomyces noursei</span>.</p><p>Structural formula:</p><p>C <span class="Sub">47</span>H <span class="Sub">75</span>NO <span class="Sub">17</span>     MW 926.13</p><p>Nystatin Oral Suspension USP, for oral administration, contains 100,000 USP Nystatin Units per mL. Inactive ingredients: alcohol (≤ 1% v/v), artificial peppermint flavor, cherry flavor, citric acid, D&amp;C Yellow No. 10, FD&amp;C Red No. 40, glycerin, magnesium aluminum silicate, methylparaben, potassium phosphate dibasic, propylene glycol, propylparaben, purified water and sucrose.</p><h2>Nystatin Oral Suspension - Clinical Pharmacology</h2><h3>Pharmacokinetics</h3><p class="First">Gastrointestinal absorption of nystatin is insignificant. Most orally administered nystatin is passed unchanged in the stool. In patients with renal insufficiency receiving oral therapy with conventional dosage forms, significant plasma concentrations of nystatin may occasionally occur.</p><h3>Microbiology</h3><p class="First">Nystatin is both fungistatic and fungicidal <span class="Italics">in vitro</span> against a wide variety of yeasts and yeast-like fungi. <span class="Italics">Candida albicans</span> demonstrates no significant resistance to nystatin <span class="Italics">in vitro</span> on repeated subculture in increasing levels of nystatin; other <span class="Italics">Candida</span> species become quite resistant. Generally, resistance does not develop <span class="Italics">in vivo</span>. Nystatin acts by binding to sterols in the cell membrane of susceptible <span class="Italics">Candida</span> species with a resultant change in membrane permeability allowing leakage of intracellular components. Nystatin exhibits no appreciable activity against bacteria, protozoa, or viruses.</p><h2>Indications and Usage for Nystatin Oral Suspension</h2><p class="First">Nystatin Oral Suspension is indicated for the treatment of candidiasis in the oral cavity.</p><h2>Contraindications</h2><p class="First">The preparation is contraindicated in patients with a history of hypersensitivity to any of its components.</p><h2>Precautions</h2><h3>General</h3><p class="First">This medication is not to be used for the treatment of systemic mycoses. Discontinue treatment if sensitization or irritation is reported during use.</p><h3>Carcinogenesis, Mutagenesis, Impairment of Fertility</h3><p class="First">No long-term animal studies have been performed to evaluate carcinogenic potential. There also have been no studies to determine mutagenicity or whether this medication affects fertility in males or females.</p><h3>Pregnancy</h3><p class="First">Animal reproduction studies have not been conducted with Nystatin Oral Suspension. It is also not known whether Nystatin Oral Suspension can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Nystatin Oral Suspension should be given to a pregnant woman only if clearly needed.</p><h3>Nursing Mothers</h3><p class="First">It is not known whether nystatin is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when nystatin is administered to a nursing woman.</p><h3>Pediatric Use</h3><p class="First">See <span class="Bold">DOSAGE AND ADMINISTRATION</span>.</p><h2>Adverse Reactions</h2><p class="First">Nystatin is well tolerated even with prolonged therapy. Oral irritation and sensitization have been reported. (See <span class="Bold">PRECAUTIONS: General</span>).</p><p><span class="Italics">Gastrointestinal:</span> Diarrhea (including one case of bloody diarrhea), nausea, vomiting, gastrointestinal upset/disturbances.</p><p><span class="Italics">Dermatologic:</span> Rash, including urticaria has been reported rarely. Stevens-Johnson syndrome has been reported very rarely.</p><p><span class="Italics">Other:</span> Tachycardia, bronchospasm, facial swelling, and non-specific myalgia have also been rarely reported.</p><h2>Overdosage</h2><p class="First">Oral doses of nystatin in excess of five million units daily have caused nausea and gastrointestinal upset. There have been no reports of serious toxic effects of superinfections (See <span class="Bold">CLINICAL PHARMACOLOGY, Pharmacokinetics</span>).</p><h2>Nystatin Oral Suspension Dosage and Administration</h2><p class="First">INFANTS: 2 mL (200,000 units) four times daily (in infants and young children, use dropper to place one-half of dose in each side of mouth and avoid feeding for 5 to 10 minutes).</p><p>NOTE: Limited clinical studies in premature and low birth weight infants indicate that 1 mL four times daily is effective.</p><p>CHILDREN AND ADULTS: 4 to 6 mL (400,000 to 600,000 units) four times daily (one-half of dose in each side of mouth). The preparation should be retained in the mouth as long as possible before swallowing.</p><p>Continue treatment for at least 48 hours after perioral symptoms have disappeared and cultures demonstrate eradication of <span class="Italics">Candida albicans</span>.</p><h2>How is Nystatin Oral Suspension Supplied</h2><p class="First">Nystatin Oral Suspension USP, 100,000 USP Nystatin Units per mL, is available in a cherry, peppermint flavored, light creamy yellow, ready-to-use suspension, supplied in the following oral dosage forms:</p><p>Overbagged with 5 x 5 mL unit dose cups, NDC 55154-5788-5</p><h3>Storage</h3><p class="First">Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Avoid freezing.</p><p class="First"><span class="Bold">R01/20</span></p><p><span class="Bold"><span class="Italics">Pharmaceutical Associates, Inc.</span></span><br/>
Greenville, SC 29605<br/>
www.paipharma.com</p><p>Distributed by:<br/>
Cardinal Health</p><p>Dublin, OH 43017</p><p>L56770751220</p><h2>Package/Label Display Panel</h2><p class="First">Nystatin Oral Suspension, USP</p><p>500,000 Units/ 5 mL</p><p>5 Unit Dose Cups</p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>Can triamcinolone acetonide B be used to treat severe diaper rash on a little girl?</li>
</ul><h2>More about nystatin</h2><ul class="more-resources-list more-resources-list-general">
<li>Side Effects</li>
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Support Group</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>64 Reviews</li>
<li>Drug class: mouth and throat products</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Nystatin &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(Advanced Reading)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li>Nystatin Tablets &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(FDA)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
<li>Nystatin Vaginal Insert &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(FDA)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Gastrointestinal Candidiasis</li>
<li>Oral Thrush</li>
</ul><p class="ddc-disclaimer-link">Medical Disclaimer</p></body></html>